DKRT Investments’s Thermo Fisher Scientific TMO Stock Holding History

DKRT Investments’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.1M	Hold	42,000	–	–	5.15%	7
2026 Q1	$20.6M	Buy	+42,000	New	+$22.8M	5.23%	8
2025 Q4	–	Sell	-30,300	Closed	-$14.7M	–	48
2025 Q3	$14.7M	Hold	30,300	–	–	3.53%	9
2025 Q2	$12.3M	Buy	+30,300	New	+$12.7M	2.98%	9

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DKRT Investments's TMO Position: Q2 2026 in Review

DKRT Investments held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 42,000 shares worth $21.1M. The position accounts for 5.15% of the portfolio, ranked #7.

DKRT Investments first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. 2,605 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

DKRT Investments held 42,000 shares of Thermo Fisher Scientific worth $21.1M as of Q2 2026.
DKRT Investments left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 5.15% of DKRT Investments's portfolio in Q2 2026, its #7 holding.
DKRT Investments first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
2,605 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on DKRT Investments's 13F filing for Q2 2026, filed 13 Aug 2026.